close
MENU
4 mins to read

Editor's Insight: The inside story on drug prices

A new report says New Zealanders are last in line for new medicines.

Tue, 24 Mar 2015

Listen to more in-depth analysis from Nevil Gibson on NBR Radio

A new Australian report confirms what anyone needing prescription medicines already knows: New Zealanders have the worst access to new treatments among world’s most developed countries.

To some, this is an achievement to be praised –

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Editor's Insight: The inside story on drug prices
46310
true